- Home
- EBAY vs TAK Comparison
EBAY vs TAK Comparison
Compare EBAY & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EBAY | TAK |
|---|---|---|
| Founded | 1995 | 1781 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.4B | 43.3B |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | EBAY | TAK |
|---|---|---|
| Price | $82.79 | $14.60 |
| Analyst Decision | Buy | |
| Analyst Count | 28 | 0 |
| Target Price | ★ $94.12 | N/A |
| AVG Volume (30 Days) | ★ 3.8M | 2.6M |
| Earning Date | 10-29-2025 | 01-29-2026 |
| Dividend Yield | 1.36% | ★ 3.68% |
| EPS Growth | ★ 16.01 | N/A |
| EPS | ★ 4.60 | 0.14 |
| Revenue | $10,714,000,000.00 | ★ $29,846,840,032.00 |
| Revenue This Year | $9.21 | N/A |
| Revenue Next Year | $4.65 | $0.59 |
| P/E Ratio | ★ $18.82 | $102.85 |
| Revenue Growth | ★ 4.36 | N/A |
| 52 Week Low | $58.71 | $12.80 |
| 52 Week High | $101.15 | $15.69 |
Technical Indicators
Market Signals| Indicator | EBAY | TAK |
|---|---|---|
| Relative Strength Index (RSI) | 45.23 | 61.62 |
| Support Level | $82.26 | $14.20 |
| Resistance Level | $85.66 | $14.53 |
| Average True Range (ATR) | 1.90 | 0.14 |
| MACD | 0.47 | 0.01 |
| Stochastic Oscillator | 44.59 | 98.81 |
Price Performance
Historical ComparisonAbout EBAY eBay Inc.
EBay operates one of the largest e-commerce marketplaces in the world, with $75 billion in 2024 gross merchandise volume, rendering the firm a top 10 global e-commerce company. It generates sales from listing fees, advertising, revenue-sharing arrangements with service providers, and managed payments, with its platform connecting more than 130 million buyers and roughly 20 million sellers across almost 190 global markets at the end of 2024. EBay generates just north of 50% of its GMV in international markets, with a large presence in the UK, Germany, and Australia.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.